Aurinia Pharmaceuticals Inc.: Form SCHEDULE 13D/A, filed Aug 26, 2026
Filed with the SEC on Aug 26, 2026 and accepted by EDGAR at Aug 26, 2026, 21:24 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001104659-26-101785. Last ingested by Listed: Oct 30, 2026, 08:08 ET. Listed shows no prices and gives no investment advice.